20^th European Gastroenterology and Therapeutics Congress

Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis

Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic condition that significantly impacts patients’ quality of life. This session focuses on the latest advancements in pathogenesis, diagnostics, and management strategies for IBD. With growing insights into the role of the microbiome, immune dysregulation, and genetic susceptibility, targeted biologic and small molecule therapies are transforming treatment paradigms. The session explores novel therapeutic agents, including JAK inhibitors, S1P modulators, and anti-integrins, as well as personalized treatment approaches based on therapeutic drug monitoring. Innovations in imaging and endoscopic technologies are also improving disease monitoring and mucosal healing assessments. Special emphasis will be given to pediatric IBD, post-surgical recurrence, nutrition therapy, and extraintestinal manifestations. Attendees will gain insights into multidisciplinary IBD care, patient education, and emerging research on disease modification and remission strategies. The goal is to optimize clinical outcomes and long-term disease management through precision medicine.